This is an Aurora Health Care system registry of patients receiving accelerated partial breast irradiation and external beam.
Study Type
OBSERVATIONAL
Enrollment
145
Aurora BayCare Medical Center
Green Bay, Wisconsin, United States
The collection and analysis of sufficient data to determine 5 and 10-year local recurrence rates is collection and analysis of sufficient data to determine 5 and 10-year local recurrence rates
The primary endpoint of this registry trial is collection and analysis of sufficient data to determine 5 and 10-year local recurrence rates for each PBI type used and for the overall Aurora population. The following endpoints will also be reported and analyzed: * Disease Free Survival * Regional Recurrence * Distant Metastasis * Combined Recurrence
Time frame: 5 and 10-year local recurrence rates
collection and analysis of data to evaluate and compare cosmetic outcome
The secondary endpoint is the collection and analysis of data to evaluate and compare cosmetic outcome (per Harvard Score) and toxicities/complications for each PBI type (per Common Terminology Criteria for Adverse Events (referred to as CTC or CTCAE))
Time frame: 5 and 10-year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.